Find new investment opportunities based on Market Sentiment Indicator. Manage watchlist risk with leading indicator of volatility See what influential analysts and investors are saying about stocks in your watchlist
$DRRX DURECT Corporation exploded higher by over 240% after Bausch Health announced a $63 million buyout of the company. The key asset driving the deal is Larsucosterol, a late-stage-ready treatment for alcoholic hepatitis (AH), which currently has no FDA-approved options. With Bausch's robust hepatology infrastructure, investors are betting big on the potential market impact of this treatment. The acquisition at $1.75 per share sent DRRX skyrocketing well beyond that price on speculative enthusiasm and short covering. The volume today was astronomical, with nearly 50 million shares trading hands versus an average of just 54,000.
$XPRO Expro Group jumped over 32% after delivering a clean beat on both revenue and earnings. The oilfield services company not only outperformed expectations in Q2 but also reaffirmed its FY25 guidance, giving investors confidence in its operational strength despite ongoing industry volatility. The surge in volume and investor interest signals that this name may be entering a new phase of revaluation.
$MFH Mercurity Fintech rose 22.7%, an ironic twist after the company canceled a planned direct offering. While such cancellations are typically bearish, in this case, investors cheered the move, perhaps interpreting it as a positive signal that the company sees no immediate cash need or dilution pressure. The stock’s momentum today suggests short-term traders are driving the action.
$CVLT Commvault Systems popped 18.3% after reporting stronger-than-expected results, with non-GAAP EPS of $1.01 beating by $0.04 and revenue topping consensus by $14 million. With demand for data protection and management remaining resilient, investors rewarded CVLT’s solid execution and upbeat outlook.
$AMKR Amkor Technology gained 18.2% on the back of stellar Q2 results and strong Q3 guidance. EPS and revenue both topped Street estimates, and the company guided higher for the next quarter, citing robust demand across all end markets. Shares also crossed their 200-day moving average, a bullish technical signal that likely brought in trend-following traders and institutions. Analysts are already upgrading their forecasts, and options traders are exploring yield-boosting strategies, adding to the buzz.
Yesterday at 08:34
Yesterday at 08:22
Yesterday at 10:09
Join StocksRunner.com for daily market updates, expert analyses, and actionable insights.
Signup now for FREE and stay ahead of the market curve!
Find out what 10,000+ subscribers already know.
Real-time insights for informed decisions.
Limited slots available, SignUp Now!
Please note that the content above should not be considered as investment advice or marketing. It does not take into account the personal data and requirements of any individual. This content is not a substitute for the reader's own judgment and should not be considered as advice or a recommendation for buying or selling any securities or financial products.
Get all the pieces of the puzzle on important data activity before the major news sources break the story and find out what happening right now and what could happen in the future
Join over 10,000+ subscribers who value exclusive insights. Stay ahead in the stock market! Enter your email for daily alerts
Real-time stock market updates
Expert stock analysis
Investment strategies
Top stock recommendations
Trading signals and opportunities
Discover what is happening right now and piece together the key data activity before the major news outlets catch on. Stay ahead of the trends
FIND US ON
Unlock the knowledge that 10,000+ subscribers already cherish. Join for exclusive insights and stay ahead in the stock game! Enter your email to receive daily alerts
In-depth stock analysis
Informed investment decisions
Stock market insights
Stock trading tips
Disclaimer:
The Score performance whether actual or indicated by historical tests of strategies, is no guarantee of future performance or success. The results reflect performance of a strategy not historically offered to investors and does not represent returns that any investor actually attained.
The results reflect performance of a strategy not historically offered to investors and does not represent returns that any investor actually attained. The Readiness Indicators, Sentiment Indicators and total score are calculated by the retroactive application of a model constructed on the basis of historical data and based on assumptions integral to the model which may or may not be testable and are subject to losses. Active trading is generally not appropriate for someone of limited resources, limited invesment or trading experience, or low-risk tolerance. Your capital may be at risk.
Please note that no offer or solicitation to buy or sell securities, securities derivatives of future products of any kind, or any type of trading or invesment advise, recommendation or strategy, is made, given or endorsed by StocksRunner including any of their affiliates ("TS").
This information is provided for illustrative purposes only. You should not rely on any advice and/or information contained in this website and before making any investment decision. we recommend that you consider whether it is appropriate for your situation and seek appropriate financial, taxation and legal advice.